Advertisement · 728 × 90

Posts by EDLundereng

Preview
Balancing ideals and realities: health care professionals’ perspectives of and attitudes toward digital patient-centered cancer care - Quality of Life Research Purpose Patient-centered care (PCC) improves quality of life, symptom management and healthcare outcomes in oncology. However, integration into routine cancer care remains limited. Digital solutions u...

I am excited to share my research is now published! 📚
Balancing ideals and realities: health care professionals’ perspectives of and attitudes toward digital patient-centered cancer care
link.springer.com/article/10.1...
@springernature.com and #SNAuthor.

1 month ago 1 0 0 0
Post image Post image Post image

New publication in QuRE📄 How do healthcare professionals navigate the shift to digital patient-centered cancer care?
​Our study highlights the tension between ideals and clinical reality, offering insights for future #eHealth implementation.
​Open access: rdcu.be/e4A6k

2 months ago 2 0 0 0
Post image

Humbled and grateful to be part of the EU-funded MyPath project, and to see our research on patient-centered cancer care recognized on #WorldCancerResearchDay. Looking forward to continuing working towards more patient-centered cancer care in Europe!

6 months ago 1 0 0 0

Were these patients who transitioned from oncology to palliative care, or patients who presented with metastatic cancer, and were finally allowed to be relieved of their chronic pain? I have certainly encountered both.

1 year ago 0 0 1 0

"You can't shoot values" - isn't that just a win for values?

1 year ago 0 0 0 0
Improving the Implementation of ##Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative #Digital Communication Technologies Implementation of ##Patient-reported outcome measures (PROMs) in clinical practice is challenging. We believe effective communication is key to realizing the clinical benefits of PROMs. Communication processes for PROMs in clinical practice typically…

New in JMIR: Improving the Implementation of ##Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative #Digital Communication Technologies

1 year ago 0 1 0 0
Preview
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have poor 5-year survival. Pharmacological ascorbate (P-AscH-, high dose, intravenous…

Exciting Phase II results on high-dose vitamin C in PDAC! 🧪📈 tinyurl.com/msswxk6p

☣️ Potential survival benefits & better chemo tolerance
⛔️ Methodological limitations exist warranting some caution
✅️ A Phase III trial is crucial to confirm effectiveness.

Hope to see it move forward!
#WorldCancerDay

1 year ago 2 0 0 0

Great reminder that tackling cancer isn’t just about prevention and treatment - it’s also about how we care for patients. I'm proud to be part of the EU-funded #MyPathEU, developing a digital solution to make patient-centered cancer care more integrated and accessible across Europe. #WorldCancerDay

1 year ago 5 0 0 0
Advertisement